Status:
ENROLLING_BY_INVITATION
Watch and Wait or Worry and Wait in Indolent Lymphoma
Lead Sponsor:
Seoul National University Hospital
Collaborating Sponsors:
Korea University Anam Hospital
Samsung Medical Center
Conditions:
Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL)
Marginal Zone Lymphoma(MZL)
Eligibility:
All Genders
19+ years
Brief Summary
Indolent lymphomas, including chronic lymphocytic leukemia/small lymphocytic lymphoma, marginal zone lymphoma, low-grade follicular lymphoma, and Waldenström macroglobulinemia, are slow-growing cancer...
Detailed Description
This is an observational, patient-reported outcomes study of indolent lymphoma patients managed with a watch-and-wait strategy. Eligible participants include adults (≥19 years) diagnosed at Seoul Nati...
Eligibility Criteria
Inclusion
- Adults ≥19 years old.
- Diagnosed with indolent lymphoma (CLL/SLL, MZL, FL, or WM/LPL) at Seoul National University Hospital according to WHO criteria.
- Currently managed with watch-and-wait (no active systemic therapy).
- Able to understand and independently complete the study questionnaires.
- Provide voluntary informed consent.
Exclusion
- Receiving active systemic anti-lymphoma therapy at the time of enrollment.
- Cognitive impairment or other condition preventing independent completion of the questionnaire.
Key Trial Info
Start Date :
October 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 10 2027
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT07173790
Start Date
October 1 2025
End Date
September 10 2027
Last Update
November 21 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, Gangnam-gu, South Korea, 06351
2
Korea UniversityKorea University Guro Hospital
Seoul, Guro-gu, South Korea, 08308
3
Seoul National University Hospital
Seoul, Jongno-gu, South Korea
4
The Catholic University of Korea
Seoul, Seocho-gu, South Korea, 06591